Artesunate FDA Approval History
Last updated by Judith Stewart, BPharm on Dec 27, 2020.
FDA Approved: Yes (First approved May 26, 2020)
Generic name: artesunate
Dosage form: for Injection
Company: Amivas (US), LLC
Treatment for: Malaria
Artesunate for Injection is an antimalarial indicated for the initial treatment of severe malaria in adult and pediatric patients.
Development timeline for artesunate
See also
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
